Marker Therapeutics Inc (MRKR)
3.84
-0.06
(-1.41%)
USD |
NASDAQ |
Jun 03, 16:00
3.84
0.00 (0.00%)
After-Hours: 20:00
Marker Therapeutics 1 Year Total Returns (Daily): 118.8% for May 31, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| May 31, 2024 | 118.8% |
| May 30, 2024 | 201.5% |
| May 29, 2024 | 210.9% |
| May 28, 2024 | 207.0% |
| May 24, 2024 | 231.2% |
| May 23, 2024 | 218.0% |
| May 22, 2024 | 203.1% |
| May 21, 2024 | 214.3% |
| May 20, 2024 | 222.9% |
| May 17, 2024 | 216.8% |
| May 16, 2024 | 210.6% |
| May 15, 2024 | 204.4% |
| May 14, 2024 | 218.4% |
| May 13, 2024 | 227.2% |
| May 10, 2024 | 191.8% |
| May 09, 2024 | 174.7% |
| May 08, 2024 | 155.7% |
| May 07, 2024 | 179.2% |
| May 06, 2024 | 185.4% |
| May 03, 2024 | 210.3% |
| May 02, 2024 | 271.7% |
| May 01, 2024 | 319.4% |
| April 30, 2024 | 381.3% |
| April 29, 2024 | 389.1% |
| April 26, 2024 | 427.6% |
| Date | Value |
|---|---|
| April 25, 2024 | 381.9% |
| April 24, 2024 | 378.3% |
| April 23, 2024 | 356.2% |
| April 22, 2024 | 332.0% |
| April 19, 2024 | 324.6% |
| April 18, 2024 | 283.2% |
| April 17, 2024 | 281.4% |
| April 16, 2024 | 300.0% |
| April 15, 2024 | 303.6% |
| April 12, 2024 | 418.0% |
| April 11, 2024 | 447.6% |
| April 10, 2024 | 497.8% |
| April 09, 2024 | 452.9% |
| April 08, 2024 | 454.1% |
| April 05, 2024 | 443.0% |
| April 04, 2024 | 493.2% |
| April 03, 2024 | 483.2% |
| April 02, 2024 | 514.1% |
| April 01, 2024 | 547.9% |
| March 28, 2024 | 409.9% |
| March 27, 2024 | 435.3% |
| March 26, 2024 | 422.4% |
| March 25, 2024 | 485.2% |
| March 22, 2024 | 309.2% |
| March 21, 2024 | 163.6% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-92.22%
Minimum
Jun 14 2022
547.9%
Maximum
Apr 01 2024
-18.03%
Average
-46.01%
Median
1 Year Total Returns (Daily) Benchmarks
| AIM ImmunoTech Inc | -21.93% |
| Perspective Therapeutics Inc | 160.4% |
| Protalix BioTherapeutics Inc | -45.93% |
| Electromed Inc | 25.06% |
| Armata Pharmaceuticals Inc | 103.0% |